Product logins

Find logins to all Clarivate products below.


Biosurgical Agents | Market Insights | Latin America | 2021

Although it will be negatively impacted in the short term by the COVID-19 pandemic, the biosurgical agent market in Latin America will grow at a modest rate through 2029, primarily driven by favorable demographics, rising awareness of the clinical benefits of these products on surgical outcomes, and the introduction of new products with enhanced features and expanded indications.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for biosurgical agents in the US across a 10-year period.

Related Medtech Insights Reports

Report
Sports Medicine Devices – Market Insights – Latin America
The Latin American sports medicine device market will see moderate growth, driven by the rise of underpenetrated procedures—such as meniscus repair and ligament reconstruction—alongside the…
Report
Small-Joint Reconstructive Implants – Market Insights – Latin America
The Latin American small-joint reconstructive implant market remains significantly underpenetrated relative to the US and European markets, offering substantial growth potential, particularly in…
Report
Neurovascular Devices – Market Insights – Latin America
The Latin American neurovascular device market is poised to experience moderate growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing…
Report
Transcatheter Embolization and Occlusion Devices – Market Insights – Latin America
The Latin American TEO device market is poised to experience moderate growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing adoption of…
Report
Transcatheter Embolization and Occlusion Devices | Market Insights | Latin America (Supplemental) | 2023
Although COVID-19 has negatively impacted the Latin American transcatheter embolization and occlusion device market, the impact of COVID-19 has been limited. The market will expand at a modest rate…